Sorry for interrupting, this website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Learn more
Accept & Close

Market Re-forecasts: Health and Wellbeing - US - April 2009

Mintel has undertaken some bold initiatives that provide crucial insight into current market conditions and approaches to a range of markets moving forward. Most dramatically, Mintel conducted an exhaustive re-evaluation of consumer market forecasts of our reports.

What this means is that you can now see, in a side-by-side comparison, how Mintel viewed the market at the time a report was published, and how we view projected market growth given the current recession. Each reforecast includes a brief statement of the new forecast, reasons for the change, and an overall assessment of the current state of the market.

In addition, you'll find value in Mintel Oxygen's What's Hot, Economy in Crisis page, which provides the latest in trends, market reactions and opportunities.

What you get

What's included

Why buy from us?

Succeed

Our reports will provide you with market data, consumer research and competitive intelligence to succeed in your market.

Instant Access

Buy now and you'll have instant access to the information you need to make the right decisions.

Opportunities

Find out what's next in the markets that matter to you: where opportunities lie and what challenges you will face.

Trusted

A business Superbrand, Mintel is a source you can trust. We have been defining and refining the Market Intelligence mix since 1972.

Table of contents

  1. Introduction: Reforecasting Puts Markets in Fresh Light

    • Intelligent planning brings opportunities
      • Fresh insight for making smart decisions
      • Cigarettes and Smoking Cessation Aids

        • Key points
          • Cessation aid market size and forecast January 12, 2009
            • Figure 1: Total U.S. sales of cessation aids, at current prices, 2003-13
            • Figure 2: Total U.S. sales of cessation aids, at inflation-adjusted prices, 2003-13
          • Cigarette and tobacco products size and forecast – January 12, 2009
            • Figure 3: Total U.S. sales and forecast of cigarettes and tobacco products, at current prices, 2003-13
            • Figure 4: Total U.S. sales and forecast of cigarettes and tobacco products, at inflation-adjusted prices, 2003-13
          • Market size and forecast originally published March 2008
            • Figure 5: Total U.S. sales and forecast of cigarettes and tobacco products, at current prices, 2003-11
            • Figure 6: Total U.S. sales and forecast of cigarettes and tobacco products, at constant prices, 2003-11
            • Figure 7: U.S. FDMx sales and forecast of smoking cessation products, at current prices, 2003-11
            • Figure 8: U.S. FDMx sales and forecast of smoking cessation products, at current prices and constant prices, 2003-11
            • Figure 9: U.S. FDMx sales and forecast of smoking cessation products, at current prices, 2003-11
            • Figure 10: U.S. FDMx sales and forecast of smoking cessation products, at current prices and constant prices, 2003-11
        • Cold, Flu and Allergy Remedies

          • Key points
            • Market size and forecast - January 12, 2009
              • Figure 11: Total U.S. retail sales of cold, flu, and allergy remedies, at current prices, 2003-13
              • Figure 12: Total U.S. retail sales of cold, flu, and allergy remedies, at inflation-adjusted prices, 2003-13
            • Tablets
              • Figure 13: Total U.S. retail sales of cold, flu, and allergy tablets, at current prices, 2003-13
            • Liquids
              • Figure 14: Total U.S. retail sales of cold, flu, and allergy liquids, at current prices, 2003-13
            • Nasal products
              • Figure 15: Total U.S. retail sales of cold, flu, and allergy nasal products, at current prices, 2003-13
            • Market size and forecast originally published October 2007
              • Figure 16: Total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
              • Figure 17: Forecast of total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2007-12
              • Figure 18: Sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2002-07
              • Figure 19: Forecast of U.S. FDM sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2007-12
              • Figure 20: Sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2002-07
              • Figure 21: Forecast of U.S. FDM sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2007-12
              • Figure 22: Sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2002-07
              • Figure 23: Forecast of U.S. FDM sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2007-12
          • Contraceptives

            • Key points
              • Market size and forecast – January 12, 2009
                • Figure 24: OTC (FDMx and convenience store) sales and forecast of contraceptives, at current prices, 2003-13
                • Figure 25: OTC (FDMx and convenience store) sales and forecast of contraceptives, at inflation-adjusted prices, 2003-13
                • Figure 26: Condom market size and forecast, at current prices, 2003-13
                • Figure 27: Condom market size and forecast, at inflation-adjusted prices, 2003-13
                • Figure 28: Female condoms, spermicidal, and Plan B, at current prices, 2003-13
                • Figure 29: Female condoms, spermicidal, and Plan B at inflation-adjusted prices, 2003-13
                • Figure 30: Lubricants and enhancements sales and forecast, at current prices, 2003-13
                • Figure 31: Lubricants and enhancements sales and forecast, at inflation-adjusted prices, 2003-13
              • Market size and forecast originally published from June 2008
                • Figure 32: OTC (FDMx and convenience store) sales and forecast of contraceptives, at current prices, 2002-12
                • Figure 33: OTC (FDMx and convenience store) sales and forecast of contraceptives, at inflation adjusted prices, 2002-12
                • Figure 34: U.S. sales and forecast of condoms at FDMx and C-stores, at current prices, 2002-12
                • Figure 35: U.S. sales and forecast of condoms at FDMx and C-stores, at inflation-adjusted prices, 2002-12
                • Figure 36: U.S. sales and forecast of lubrication and enhancement products, at current prices, 2002-12
                • Figure 37: U.S. sales and forecast of lubrication and enhancement products, at inflation-adjusted products, 2002-12
            • Cough and Throat Remedies

              • Key points
                • Market size and forecast - January 29, 2009
                  • Figure 38: FDMx and c-store sales and forecast of cough and throat remedies, at current prices, 2003-13
                  • Figure 39: FDMx and c-store sales and forecast of cough and throat remedies, at inflation-adjusted prices, 2003-13
                  • Figure 40: FDMx and c-store sales and forecast of cough drops, at current prices, 2003-13
                  • Figure 41: FDMx and c-store sales and forecast of cough syrups, at current prices, 2003-13
                  • Figure 42: FDMx and c-store sales and forecast of sore throat liquids, at current prices 2003-13
                • Market size and forecast originally published from May 2008
                  • Figure 43: Total FDMx and c-store sales and forecast of cough and throat remedies, at current prices, 2002-12
                  • Figure 44: Total FDMx and c-store sales and forecast of cough and throat remedies, at inflation-adjusted prices, 2002-12
                  • Figure 45: U.S. FDMx sales and forecast of cough drops, at current prices, 2002-12
                  • Figure 46: U.S. FDMx sales and forecast of cough syrups, at current prices, 2002-12
                  • Figure 47: U.S. FDMx sales and forecast of sore throat liquids, at current prices, 2002-12
              • First Aid

                • Key points
                  • Market size and forecast – January 12, 2009
                    • Figure 48: U.S. FDMx sales of first aid accessories and treatment, at current prices, 2003-13
                    • Figure 49: U.S. FDMx sales of first aid accessories and treatment, at inflation-adjusted prices, 2003-13
                    • Figure 50: U.S. FDMx sales and forecast of first aid accessories*, at current prices, 2003-13
                    • Figure 51: U.S. FDMx sales and forecast of first aid treatments*, at current prices, 2003-13
                  • Market size and forecast originally published July 2008
                    • Figure 52: U.S. FDMx sales of first aid accessories and treatment, at current prices, 2002-12
                    • Figure 53: U.S. FDMx sales of first aid accessories and treatment, at inflation adjusted prices, 2002-12
                    • Figure 54: U.S. FDMx sales and forecast of first aid accessories*, at current prices, 2002-12
                    • Figure 55: U.S. FDMx sales and forecast of first aid treatments*, at current prices, 2002-12
                • Functional Beverages

                  • Key points
                    • Figure 56: FDMx sales and forecast of functional beverages, at current prices, 2003-13
                    • Figure 57: FDMx sales and forecast of functional beverages, at inflation-adjusted prices, 2003-13
                    • Figure 58: FDMx sales and forecast of functional juice and juice drinks, at current prices, 2003-13
                    • Figure 59: U.S. FDMx sales and forecast of enhanced water, at current prices, 2003-13
                    • Figure 60: FDMx sales and forecast of energy drinks, at current prices, 2003-13
                    • Figure 61: FDMx sales and forecast of functional tea, at current prices, 2003-11
                    • Figure 62: FDMx sales and forecast of functional yogurt drinks and smoothies, at current prices, 2003-11
                    • Figure 63: U.S. FDMx sales and forecast of functional soy-, almond- and rice-based drinks, at current prices, 2003-11
                  • Market size and forecast originally published from August 2008
                    • Figure 64: FDMx sales and forecast of functional beverages, at current prices, 2003-11
                    • Figure 65: FDMx sales and forecast of functional beverages, at inflation-adjusted prices, 2003-11
                    • Figure 66: FDMx sales and forecast of functional juice and juice drinks, at current prices, 2003-11
                    • Figure 67: U.S. FDMx sales and forecast of enhanced water, at current prices, 2003-11
                    • Figure 68: FDMx sales and forecast of energy drinks, at current prices, 2003-11
                    • Figure 69: FDMx sales and forecast of functional tea, at current prices, 2003-11
                    • Figure 70: FDMx sales and forecast of functional yogurt drinks and smoothies, at current prices, 2003-11
                    • Figure 71: U.S. FDMx sales and forecast of functional soy-, almond- and rice-based drinks, at current prices, 2003-11
                • Gastrointestinal Remedies

                  • Key points
                    • Market size and forecast - January 12, 2009
                      • Figure 72: Total U.S. sales and forecast of gastrointestinal remedies, at current prices, 2003-13
                      • Figure 73: Total U.S. sales and forecast of gastrointestinal remedies, at inflation-adjusted prices, 2003-13
                      • Figure 74: FDMx sales and forecast of antacids, at current prices, 2003-13
                      • Figure 75: FDMx sales and forecast of antacids, at inflation-adjusted prices, 2003-13
                      • Figure 76: U FDMx sales and forecast of laxatives, at current prices, 2003-13
                      • Figure 77: FDMx sales and forecast of laxatives, at inflation-adjusted prices, 2003-13
                      • Figure 78: FDMx sales and forecast of anti-diarrheals, at current prices, 2003-13
                      • Figure 79: FDMx sales and forecast of anti-diarrheals, at inflation-adjusted prices, 2003-13
                      • Figure 80: FDMx sales and forecast of stomach remedies, at current prices, 2003-13
                      • Figure 81: FDMx sales and forecast of stomach remedies, at inflation-adjusted prices, 2003-13
                    • Market size and forecast originally published September 2008
                      • Figure 83: Total U.S. sales and forecast of gastrointestinal remedies, at inflation-adjusted prices, 2003-13
                      • Figure 84: FDMx sales and forecast of antacids, 2003-13*
                      • Figure 85: FDMx sales and forecast of laxatives, 2003-13
                      • Figure 86: FDMx sales and forecast of anti-diarrheals, 2003-13
                      • Figure 87: FDMx sales and forecast of stomach remedies, 2003-13
                  • Glasses and Contact Lenses

                    • Key points
                      • Market size and forecast – January 12, 2009
                        • Figure 88: Total U.S. sales and forecast of glasses and contact lenses, at current prices, 2003-13
                        • Figure 89: Total U.S. sales and forecast of glasses and contact lenses, at inflation-adjusted prices*, 2003-13
                      • Market size and forecast originally published from April 2008
                        • Figure 90: Total U.S. sales and forecast of glasses and contact lenses, at current prices, 2002-12
                        • Figure 91: Total U.S. sales and forecast of glasses and contact lenses, at inflation-adjusted prices*, 2002-12
                        • Figure 92: Total U.S. sales and forecast of prescription eyeglasses, at current prices, 2002-12
                        • Figure 93: Total U.S. sales and forecast of prescription eyeglasses, at inflation-adjusted prices*, 2002-12
                        • Figure 94: Total U.S. sales and forecast of contact lenses, at current prices, 2002-12
                        • Figure 95: Total U.S. sales and forecast of contact lenses, at inflation-adjusted prices*, 2002-12
                        • Figure 96: Total U.S. sales and forecast of off-the-shelf glasses and sunglasses, at current prices, 2002-12
                        • Figure 97: Total U.S. sales and forecast of off-the-shelf glasses and sunglasses, at inflation-adjusted prices*, 2002-12
                        • Figure 98: Total U.S. sales and forecast of contact lens care products, at current prices, 2002-12
                        • Figure 99: Total U.S. sales of contact lens care products, at inflation-adjusted prices*, 2002-12
                        • Figure 100: Total U.S. sales and forecast of all other optical goods and accessories, at current prices, 2002-12
                        • Figure 101: Total U.S. sales and forecast of all other optical goods and accessories, at inflation-adjusted prices*, 2002-12
                    • Hair Loss Remedies

                      • Key points
                        • Market size and forecast originally published December 2008
                          • Figure 102: U.S. sales of hair loss remedies, at current prices, 2003-11
                          • Figure 103: U.S. sales of hair loss remedies, at inflation-adjusted prices, 2003-11
                          • Figure 104: U.S. sales and forecast of prescription hair loss remedies, 2003-11
                          • Figure 105: FDMx sales of OTC hair loss remedies, 2003-11
                      • Health and Fitness Clubs

                        • Key points
                          • Market size and forecast - January 12, 2009
                            • Figure 106: Health and fitness clubs total revenues, at current prices, 2003-13
                            • Figure 107: Health and fitness clubs total revenues, at inflation-adjusted prices, 2003-13
                          • Market size and forecast originally published June 2008
                            • Figure 108: Health and fitness clubs total revenues, at current prices, 2002-12
                            • Figure 109: Health and fitness clubs total revenues, at inflation adjusted prices, 2002-12
                        • Nuts and Dried Fruit

                          • Key points
                            • Market size and forecast, March 2009
                              • Figure 110: Total U.S. sales and forecast of nuts and dried fruit through all channels, at current prices, 2003-13
                              • Figure 111: Total U.S. sales and forecast of nuts and dried fruit through all channels, at inflation adjusted prices, 2003-13
                            • Segment sales and forecast March 2009
                              • Figure 112: Sales of snack nuts and seeds, 2003-13
                              • Figure 113: Sales of dried fruit, 2003-13
                              • Figure 114: Sales of baking nuts, 2003-13
                              • Figure 115: Sales of trail mix, 2003-13
                            • Market size and forecast originally published from July 2007
                              • Figure 116: U.S. retail sales of nuts and dried fruit through all channels, at current and constant prices, 2001-06
                              • Figure 117: Forecast of total U.S. retail sales of nuts and dried fruit through all channels, at current and constant prices, 2007-12
                          • Oral Care

                            • Key points
                              • Market size and forecast – January 31, 2009
                                • Figure 118: U.S. FDMx sales and forecast of oral care and dental hygiene products, at current prices, 2003-13
                                • Figure 119: U.S. FDMx sales and forecast of oral care and dental hygiene products, at inflation-adjusted prices, 2003-13
                              • Market size and forecast originally published June 2008
                                • Figure 120: U.S. FDMx sales and forecast of oral care and dental hygiene products, at current prices, 2002-12
                                • Figure 121: U.S. FDMx sales and forecast of oral care and dental hygiene products, at inflation-adjusted prices, 2002-12
                            • Organic Beverages

                              • Key points
                                • Market size and forecast - January 12, 2009
                                  • Figure 122: Total U.S. sales and forecast of organic beverages, at current prices, 2003-13
                                  • Figure 123: Total U.S. sales and forecast of organic beverages, at inflation-adjusted prices, 2003-13
                                  • Figure 124: U.S. sales and forecast of non-dairy beverages, at current prices, 2003-13
                                  • Figure 125: U.S. sales and forecast organic dairy beverages, at current prices, 2003-13
                                • Market size and forecast originally published from September 2008
                                  • Figure 126: Total U.S. sales and forecast of organic beverages, at current prices, 2003-13
                                  • Figure 127: Total U.S. sales and forecast of organic beverages, at inflation-adjusted prices, 2003-13
                                  • Figure 128: U.S. sales and forecast of non-dairy beverages, at current prices, 2003-13
                                  • Figure 129: U.S. sales and forecast organic dairy beverages, at current prices, 2003-13
                              • Organic Food

                                • Key points
                                  • Market size and forecast - January 12, 2009
                                    • Figure 130: Total U.S. sales and forecast of organic food, at current prices, 2003-13
                                    • Figure 131: Total U.S. sales and forecast of organic food, at inflation adjusted prices, 2003-13
                                    • Figure 132: U.S. sales and forecast of organic prepared and packaged food, at current prices, 2003-13
                                    • Figure 133: U.S. sales and forecast of organic fruit and vegetables, at current prices, 2003-13
                                    • Figure 134: U.S. sales and forecast of organic snacks, at current prices, 2003-13
                                    • Figure 135: U.S. sales and forecast of organic grain products, at current prices, 2003-13
                                    • Figure 136: U.S. sales and forecast of organic dairy products, at current prices, 2003-13
                                    • Figure 137: U.S. sales and forecast of organic meat, at current prices, 2003-13
                                    • Figure 138: U.S. sales and forecast of other organic food, at current prices, 2003-13
                                  • Market size and forecast originally published October 2008
                                    • Figure 139: Total U.S. sales and forecast of organic food at current prices, at current prices, 2003-13
                                    • Figure 140: Total U.S. sales and forecast of organic food, at inflation adjusted prices, 2003-13
                                    • Figure 141: U.S. sales and forecast of organic prepared and packaged food, at current prices, 2003-13
                                    • Figure 142: U.S. sales and forecast of organic fruit and vegetables, at current prices, 2003-13
                                    • Figure 143: U.S. sales and forecast of organic snacks, at current prices, 2003-13
                                    • Figure 144: U.S. sales and forecast of organic grain products, at current prices, 2003-13
                                    • Figure 145: U.S. sales and forecast of organic dairy products, at current prices, 2003-13
                                    • Figure 146: U.S. sales and forecast of organic meat, at current prices, 2003-13
                                    • Figure 147: U.S. sales and forecast of other organic food, at current prices, 2003-13
                                • OTC Analgesics

                                  • Key points
                                    • Market size and forecast – January 12, 2009
                                      • Figure 148: Total U.S. retail sales of OTC internal analgesics, at current prices, 2003-13
                                      • Figure 149: Total U.S. retail sales of OTC internal analgesics, at inflation-adjusted prices, 2003-13
                                      • Figure 150: FDM sales of OTC analgesic tablets, at current prices, 2003-13
                                      • Figure 151: FDM sales of OTC analgesic tablets, at inflation-adjusted prices, 2003-13
                                      • Figure 152: FDM sales of OTC analgesic liquids, at current prices, 2003-13
                                      • Figure 153: FDM sales of OTC analgesic liquids, at inflation-adjusted prices, 2003-13
                                      • Figure 154: FDM sales of OTC feminine pain relievers, at current prices, 2003-13
                                      • Figure 155: FDM sales of OTC feminine pain relievers, at inflation-adjusted prices, 2003-13
                                    • Market size and forecast originally published from November 2007
                                      • Figure 156: Total U.S. retail sales of OTC internal analgesics, at current and constant prices, 2002-07
                                      • Figure 157: Forecast of total U.S. retail sales of OTC internal analgesics, at current and constant prices, 2007-12
                                      • Figure 158: FDM sales of private label OTC analgesics, at current and constant prices, 2002-07
                                      • Figure 159: Forecast of U.S. FDM sales of private label OTC analgesics, at current and constant prices, 2007-12
                                      • Figure 160: FDM sales of OTC analgesic tablets, at current and constant prices, 2002-07
                                      • Figure 161: Forecast of U.S. FDM sales of OTC analgesic tablets, at current and constant prices, 2007-12
                                      • Figure 162: FDM sales of OTC analgesic liquids, at current and constant prices, 2002-07
                                      • Figure 163: Forecast of U.S. FDM sales of OTC analgesic liquids, at current and constant prices, 2007-12
                                      • Figure 164: FDM sales of OTC feminine pain relievers, at current and constant prices, 2002-07
                                      • Figure 165: Forecast of U.S. FDM sales of OTC feminine pain relievers, at current and constant prices, 2007-12
                                  • OTC Pediatrics

                                    • Key points
                                      • Market size and forecast, February 2009
                                        • Figure 166: Total U.S. FDMx sales and forecast of OTC pediatrics at current prices, 2003-13
                                        • Figure 167: Total U.S. FDMx sales and forecast of OTC pediatrics at inflation adjusted prices, 2003-13
                                        • Figure 168: U.S. FDMx sales and forecast of pediatric internal analgesics, 2003-13
                                        • Figure 169: U.S. FDMx sales and forecast of pediatric cold/allergy/sinus remedies, 2003-13
                                        • Figure 170: U.S. FDMx sales and forecast of baby formula/electrolytes, 2003-13
                                        • Figure 171: U.S. FDMx sales and forecast of pediatric vitamins, 2003-13
                                        • Figure 172: U.S. FDMx sales and forecast of pediatric nasal products, 2003-13
                                        • Figure 173: U.S. FDMx sales and forecast of pediatric GI remedies, 2003-13
                                        • Figure 174: U.S. FDMx sales and forecast of pediatric cough remedies, 2003-13
                                        • Figure 175: U.S. FDMx sales and forecast of miscellaneous pediatric health remedies, 2003-13
                                      • Market size and forecast originally published October 2008
                                        • Figure 176: Total U.S. FDMx sales and forecast of OTC pediatrics at current prices, 2003-13
                                        • Figure 177: Total U.S. FDMx sales and forecast of OTC pediatrics at inflation adjusted prices, 2003-13
                                        • Figure 178: U.S. FDMx sales and forecast of pediatric internal analgesics, 2003-13
                                        • Figure 179: U.S. FDMx sales and forecast of pediatric cold/allergy/sinus remedies, 2003-13
                                        • Figure 180: U.S. FDMx sales and forecast of baby formula/electrolytes, 2003-13
                                        • Figure 181: U.S. FDMx sales and forecast of pediatric vitamins, 2003-13
                                        • Figure 182: U.S. FDMx sales and forecast of pediatric nasal products, 2003-13
                                        • Figure 183: U.S. FDMx sales and forecast of pediatric GI remedies, 2003-13
                                        • Figure 184: U.S. FDMx sales and forecast of pediatric cough remedies, 2003-13
                                        • Figure 185: U.S. FDMx sales and forecast of miscellaneous pediatric health remedies, 2003-13
                                    • Self Diagnostics

                                      • Key points
                                        • Market size and forecast - January 29, 2009
                                          • Figure 186: Total FDMx sales and forecast of self diagnostics, at current prices, 2003-13
                                          • Figure 187: Total FDMx sales and forecast of self diagnostics, at inflation-adjusted prices, 2003-13
                                          • Figure 188: Total FDMx sales and forecast of glucose monitors, at current prices, 2003-13
                                          • Figure 189: Total FDMx sales and forecast of pregnancy tests, at current prices, 2003-13
                                          • Figure 190: Total FDMx sales and forecast of blood pressure monitors, at current prices, 2003-13
                                          • Figure 191: Total FDMx sales and forecast of ovulation tests, 2003-13
                                        • Market size and forecast originally published from January 2008
                                          • Figure 192: Total FDMx sales and forecast of self diagnostics, at current prices, 2002-12
                                          • Figure 193: Total FDMx sales and forecast of self diagnostics, at inflation-adjusted prices, 2002-12
                                          • Figure 194: Total FDMx sales and forecast of glucose monitors, at current prices, 2002-12
                                          • Figure 195: Total FDMx sales and forecast of pregnancy tests, at current prices, 2002-12
                                          • Figure 196: Total FDMx sales and forecast of blood pressure monitors, at current prices, 2002-12
                                          • Figure 197: Total FDMx sales and forecast of ovulation tests, at current prices, 2002-12
                                      • Slimming Meals

                                        • Key points
                                          • Market size and forecast March, 2009
                                            • Figure 198: U.S. sales of slimming meals, at current prices, 2003-13
                                            • Figure 199: U.S. sales of slimming meals, at inflation-adjusted prices, 2003-13
                                            • Figure 200: FDMx sales of frozen slimming meals, at current prices, 2003-13
                                            • Figure 201: FDMx sales of meal replacement drinks, at current prices, 2003-13
                                            • Figure 202: FDMx sales of sports and energy bars, at current prices, 2003-13
                                          • Market size and forecast originally published January 2007
                                            • Figure 203: U.S. sales of slimming meals, at current and constant prices, 2001-06
                                            • Figure 204: Forecast of total U.S. sales of slimming meals, at current and constant prices, 2006-11
                                            • Figure 8: FDM sales of frozen slimming meals, at current and constant prices, 2001-06
                                            • Figure 205: Forecast of U.S. FDM sales of frozen slimming meals, at current and constant prices, 2006-11
                                            • Figure 206: FDM sales of meal replacement drinks, at current and constant prices, 2001-06
                                            • Figure 207: Forecast of U.S. FDM sales of meal replacement drinks, at current and constant prices, 2006-11
                                            • Figure 208: FDM sales of sports and energy bars, at current and constant prices, 2001-06
                                            • Figure 209: Forecast of U.S. FDM sales of sports and energy bars, at current and constant prices, 2006-11
                                        • Sugar-Free Foods and Beverages

                                          • Key points
                                            • Market size and forecast, February 2009
                                              • Figure 210: U.S. sales of sugar-free gum, chocolate confectionery, non-chocolate confectionery, and carbonated beverages, at current prices, 2003-13
                                              • Figure 211: U.S. sales of sugar-free gum, chocolate confectionery, non-chocolate confectionery, and carbonated beverages, at inflation-adjusted prices, 2003-13
                                              • Figure 212: FDMx sales of sugar-free soft drinks/soda, at current prices, 2005-11
                                              • Figure 213: FDMx sales of sugar-free gum, at current prices, 2005-11
                                              • Figure 214: FDMx sales of sugar-free chocolate confectionery, at current prices, 2005-11
                                              • Figure 215: FDMx sales of sugar-free non-chocolate confectionery, at current prices, 2005-11
                                            • Market size and forecast originally published June 2007
                                              • Figure 216: U.S. sales of sugar-free gum, chocolate confectionery, non-chocolate confectionery, and carbonated beverages, at current and constant prices, 2001-06
                                              • Figure 217: Forecast of total U.S. retail sales of sugar-free gum, chocolate confectionery, non-chocolate confectionery, and carbonated beverages, at current and constant prices, 2006-11
                                              • Figure 218: FDM sales of sugar-free soft drinks/soda, at current and constant prices, 2001-06
                                              • Figure 219: Forecast of U.S. FDM sales of sugar-free soft drinks/soda, at current and constant prices, 2006-11
                                              • Figure 220: FDM sales of sugar-free gum, at current and constant prices, 2001-06
                                              • Figure 221: Forecast of U.S. FDM sales of sugar-free gum, at current and constant prices, 2006-11
                                              • Figure 222: FDM sales of sugar-free chocolate confectionery, at current and constant prices, 2001-06
                                              • Figure 223: FDM sales of sugar-free non-chocolate confectionery, at current and constant prices, 2001-06
                                          • Vitamins and Minerals

                                            • Key points
                                              • Market size and forecast – January 29, 2009
                                                • Figure 224: Total FDMx sales and forecast of vitamins and minerals, at current prices, 2003-13
                                                • Figure 225: Total FDMx sales and forecast of vitamins and minerals, at inflation-adjusted prices, 2003-13
                                                • Figure 226: Total FDMx sales and forecast of mineral supplements, at current prices, 2003-13
                                                • Figure 227: Total FDMx sales and forecast of multi-vitamins, at current prices, 2003-13
                                                • Figure 228: Total FDMx sales and forecast of 1 & 2 letter vitamins, at current prices, 2003-13
                                                • Figure 229: Total FDMx sales and forecast of liquid vitamins and minerals, at current prices 2003-13
                                              • Market size and forecast originally published from September 2007
                                                • Figure 230: Total FDMx sales and forecast of vitamins and minerals, at current prices, 2002-12
                                                • Figure 231: Total FDMx sales and forecast of vitamins and minerals, at inflation-adjusted prices, 2002-12
                                                • Figure 232: Total FDMx sales and forecast of mineral supplements, at current prices, 2002-12
                                                • Figure 233: Total FDMx sales and forecast of multi-vitamins, at current prices, 2002-12
                                                • Figure 234: Total FDMx sales and forecast of 1 & 2 letter vitamins, at current prices, 2002-12
                                                • Figure 235: Total FDMx sales and forecast of liquid vitamins and minerals, at current prices, 2002-12
                                            • Weight Control Products

                                              • Key points
                                                • Market size and forecast February, 2009
                                                  • Figure 236: Total US retail sales of weight control products at current prices, 2003-13
                                                  • Figure 237: Total US retail sales of weight control products at inflation-adjusted prices, 2003-13
                                                  • Figure 238: Total US retail sales of liquid meal replacements products at current prices, 2003-13
                                                  • Figure 239: Total US retail sales of weight control candy/pills at current prices, 2003-13
                                                • Market size and forecast originally published March 2007
                                                  • Figure 240: Total U.S. retail sales of weight control products, at current and constant prices, 2001-06
                                                  • Figure 241: Forecast of total U.S. sales of weight control products, at current and constant prices, 2006-11
                                                  • Figure 242: Total U.S. retail sales of weight control liquid/powders, at current and constant prices, 2001-06
                                                  • Figure 243: Forecast of U.S. sales of weight control liquids and powders, at current and constant prices, 2006-11
                                                  • Figure 244: Total U.S. retail sales of weight control candy/pills, at current and constant prices, 2001-06
                                                  • Figure 245: Forecast of U.S. sales of weight control candy and pills, at current and constant prices, 2006-11

                                              Companies Covered

                                              To learn more about the companies covered in this report please contact us.

                                              Market Re-forecasts: Health and Wellbeing - US - April 2009

                                              US $3,866.10 (Excl.Tax)